COVID-19

Respiratory Syncytial Virus and Incidence of Cardiovascular Events: A Nationwide Self-Controlled Case Series Analysis | Comorbidities Associated with Different Degrees of Severity in Children and Young People Hospitalized with Acute COVID-19 | SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Human Source SARS-CoV-2 Aerosol Transmission to Remote Sentinel Hamsters | Nirmatrelvir–ritonavir versus Placebo–ritonavir in Individuals with Long COVID in the USA (PAX LC): A Double-blind, Randomized, Placebo-controlled, Phase 2, Decentralized Trial | Quantitative Brain Volume Differences Between COVID-19 Patients and Non-COVID-19 Volunteers: A Systematic Review

Early Impact of RSV Vaccination in Older Adults in England | Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Associated Hospitalizations and Medically Attended COVID-19 among adults aged ≥18 years in the United States | Metformin Alleviates Inflammatory Response and Severity Rate of COVID-19 Infection in Elderly Individuals

Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern vs Wild Type: An Interplay Between Transmissibility and Immune Status | The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients with Kidney Disease: A Propensity Score–Matched Study | Effect of Pulmonary Rehabilitation for Patients with Long COVID-19: A Systematic Review and Meta-analysis of Randomized Controlled Trials

The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019 | COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant U.S. Outpatients | TGFβ Links EBV to Multisystem Inflammatory Syndrome in Children

Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus | Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study

Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 | Effect of Early and Delayed Treatment with Remdesivir on Mortality in Patients Hospitalized With COVID-19

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism | Demographic Variation in U.S. Outpatient Hydroxychloroquine and Ivermectin Use During the COVID-19 Pandemic. | COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Aged 5 to 17 Years

COVID-19 Case Fatality Rate and Infection Fatality Rate from 2020 to 2023: Nationwide Analysis in Austria |
A Randomized, Double-blind, Phase 1, Single- and Multiple-dose Placebo-controlled Study of the Safety and Pharmacokinetics of IN-006, an Inhaled Antibody Treatment for COVID-19 in Healthy Volunteers |
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19

Ten-Year Surveillance of RSV Hospitalizations in Adults: Incidence Rates and Case Definition Implications | Long-COVID Incidence Proportion in Adults and Children Between 2020 and 2024 | Effect of SARS-CoV-2 Infection on Sperm Telomere Length | Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19